Delivery Order SPE2DB20D2014-SPE2DB25FD00J
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,748.58 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $34,348.79 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 20, 2025, with completion expected by August 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $11,258.62 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at approximately $60.3K to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on April 24, 2025, with an ultimate completion date of April 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency has awarded a delivery order valued at $123,658.99 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract contains no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $16,480.94. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by September 9, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,214.72 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed-price contract with a completion date of August 14, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation. Performance will occur at...
- The Defense Logistics Agency awarded a $14,034.53 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $64,477.65 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on September 9, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $42,178.80. This firm fixed-price delivery order, which is set to be completed by July 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's corporate office location in...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD00JDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $32,737.72 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026 that serves as the company's comprehensive global pharmaceutical support mechanism. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its extensive IDC with DLA to fulfill critical pharmaceutical supply needs across military and federal healthcare systems. The company's track record with the Defense Logistics Agency demonstrates its capability to deliver a broad portfolio of medications and medical supplies through competitively awarded delivery orders with firm fixed pricing. This particular delivery order for Eliquis, a widely used anticoagulant medication, exemplifies AmerisourceBergen's role as a key vendor supporting Defense Health Agency requirements and other federal healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.7k | 9/15/25 |